CoronaVac-vaccinated kidney transplant recipients with hybrid immunity have strong neutralizing responses against Omicron and Mu variants of SARS-CoV-2
Brazilian Journal of Microbiology · 2024
DOI: 10.1007/s42770-024-01507-7 ↗Kurz gefasst
Fachartikel in der Zeitschrift Brazilian Journal of Microbiology, 2024. Verfasst von Yazmin R Arias-Murillo und 4 weiteren Autor:innen. Beteiligte Einrichtung: Coordination of the National Donation and Transplant Network, Blood Bank, Transfusion and Transplant Research Group, Instituto Nacional de Salud, Bog…. Hauptthemen laut MEDLINE: Antibodies, Neutralizing, SARS-CoV-2, Kidney Transplantation, COVID-19 Vaccines. Die Arbeit nennt 20 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: Unidad Nacional para la Gestión del Riesgo de Desastres (UNGRD), Enterritorios COL-H-ENTerritorio 1840.
Abstract (Originalsprache)
Neutralizing antibody (nAb) responses against SARS-CoV-2 variants after inactivated virus vaccine (CoronaVac) in kidney transplant recipients (KTRs) with or without SARS-CoV-2 infection history remains unclear. We aimed to evaluate the neutralizing antibody responses against emerging SARS-CoV-2 variants after two doses of CoronaVac in these patients. 22.2% of participants had hybrid immunity. Anti-spike IgG antibodies were evidenced in 44% of the patients. nAbs against B.1.111, Mu, and Omicron were detected in 28.5%, 17.9%, and 21.4% of naïve KTRs, respectively. Furthermore, nearly 100% of KTRs with hybrid immunity had nAbs against the variants evaluated. Thus, a significant proportion of infection-naïve KTRs had no detectable nAb titers against Mu and Omicron variants after two doses of the CoronaVac vaccine. However, the nAb titers were significantly higher in patients with hybrid immunity, and it was no association between the immunosuppressive regimen and the seropositivity rate of anti-SARS-CoV-2 neutralizing antibodies. Therefore, hybrid KTRs are protected against COVID-19 by emerging variants able to escape from vaccine-elicited nAbs such as Mu and Omicron.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Coordination of the National Donation and Transplant Network, Blood Bank, Transfusion and Transplant Research Group, Instituto Nacional de Salud, Bogotá, Colombia. yarias@ins.gov.co.
- Coordination of the National Donation and Transplant Network, Blood Bank, Transfusion and Transplant Research Group, Instituto Nacional de Salud, Bogotá, Colombia.
- Transplant Program, Clínica Colsanitas, Bogotá, Colombia.
- Department of Transplant Surgery, Colombiana de Trasplantes, Bogotá, Colombia.
- Instituto Nacional de Colombia, Bogotá, Colombia.
Förderung
- Unidad Nacional para la Gestión del Riesgo de Desastres (UNGRD)
- Enterritorios COL-H-ENTerritorio 1840
Zitieren
APA
Arias-Murillo, Y. R., Salinas-N, M. A., Montero, C., Giron, F., & Mercado, M. (2024). CoronaVac-vaccinated kidney transplant recipients with hybrid immunity have strong neutralizing responses against Omicron and Mu variants of SARS-CoV-2. Brazilian Journal of Microbiology. https://doi.org/10.1007/s42770-024-01507-7
Vancouver
Arias-Murillo YR, Salinas-N MA, Montero C, Giron F, Mercado M. CoronaVac-vaccinated kidney transplant recipients with hybrid immunity have strong neutralizing responses against Omicron and Mu variants of SARS-CoV-2. Brazilian Journal of Microbiology. 2024. doi:10.1007/s42770-024-01507-7
BibTeX
@article{AriasMurillo2024,
author = {Arias-Murillo, Yazmin R and Salinas-N, María A and Montero, Camilo and Giron, Fernando and Mercado, Marcela},
title = {CoronaVac-vaccinated kidney transplant recipients with hybrid immunity have strong neutralizing responses against Omicron and Mu variants of SARS-CoV-2},
journal = {Brazilian Journal of Microbiology},
year = {2024},
doi = {10.1007/s42770-024-01507-7}
}
EUVIMED